These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38966970)

  • 21. Proteome-Wide Structural Biology: An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale.
    Kaur U; Meng H; Lui F; Ma R; Ogburn RN; Johnson JHR; Fitzgerald MC; Jones LM
    J Proteome Res; 2018 Nov; 17(11):3614-3627. PubMed ID: 30222357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteome Integral Solubility Alteration (PISA) Assay in Mammalian Cells for Deep, High-Confidence, and High-Throughput Target Deconvolution.
    Zhang X; Lytovchenko O; Lundström SL; Zubarev RA; Gaetani M
    Bio Protoc; 2022 Nov; 12(22):. PubMed ID: 36532690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.
    Ong SE; Li X; Schenone M; Schreiber SL; Carr SA
    Methods Mol Biol; 2012; 803():129-40. PubMed ID: 22065222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the utility of ultrafast MS1-only proteomics in drug target discovery studies based on thermal proteome profiling method.
    Fedorov II; Bubis JA; Kazakova EM; Lobas AA; Ivanov MV; Emekeeva DD; Tarasova IA; Nazarov AA; Gorshkov MV
    Anal Bioanal Chem; 2024 Jul; 416(18):4083-4089. PubMed ID: 38744720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries.
    Fedorov II; Lineva VI; Tarasova IA; Gorshkov MV
    Biochemistry (Mosc); 2022 Sep; 87(9):983-994. PubMed ID: 36180990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic characterization of post-translational modifications in drug discovery.
    Zhai LH; Chen KF; Hao BB; Tan MJ
    Acta Pharmacol Sin; 2022 Dec; 43(12):3112-3129. PubMed ID: 36372853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometry-based proteomics in preclinical drug discovery.
    Schirle M; Bantscheff M; Kuster B
    Chem Biol; 2012 Jan; 19(1):72-84. PubMed ID: 22284356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precipitate-Supported Thermal Proteome Profiling Coupled with Deep Learning for Comprehensive Screening of Drug Target Proteins.
    Ruan C; Ning W; Liu Z; Zhang X; Fang Z; Li Y; Dang Y; Xue Y; Ye M
    ACS Chem Biol; 2022 Jan; 17(1):252-262. PubMed ID: 34989232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in high-throughput proteomic analysis].
    Wu Q; Sui X; Tian R
    Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoproteomic-enabled phenotypic screening.
    Conway LP; Li W; Parker CG
    Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical Denaturation and Protein Precipitation Approach for Discovery and Quantitation of Protein-Drug Interactions.
    Meng H; Ma R; Fitzgerald MC
    Anal Chem; 2018 Aug; 90(15):9249-9255. PubMed ID: 29995387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
    Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
    J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticle-Assisted Precipitation Screening Method for Robust Drug Target Identification.
    Lyu J; Ruan C; Zhang X; Wang Y; Li K; Ye M
    Anal Chem; 2020 Oct; 92(20):13912-13921. PubMed ID: 32933243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical stress induced protein precipitation method for drug target screening.
    Lyu J; Wang Y; Ruan C; Zhang X; Li K; Ye M
    Anal Chim Acta; 2021 Jul; 1168():338612. PubMed ID: 34051997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studying epigenetic complexes and their inhibitors with the proteomics toolbox.
    Weigt D; Hopf C; Médard G
    Clin Epigenetics; 2016; 8():76. PubMed ID: 27437033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics-based strategies in kinase drug discovery.
    Bantscheff M; Hopf C; Kruse U; Drewes G
    Ernst Schering Found Symp Proc; 2007; (3):1-28. PubMed ID: 18512284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis of Mass-Spectrometry-Based Proteomic Methods for Protein Target Discovery Using a One-Pot Approach.
    Cabrera A; Wiebelhaus N; Quan B; Ma R; Meng H; Fitzgerald MC
    J Am Soc Mass Spectrom; 2020 Feb; 31(2):217-226. PubMed ID: 32031398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An isothermal shift assay for proteome scale drug-target identification.
    Ball KA; Webb KJ; Coleman SJ; Cozzolino KA; Jacobsen J; Jones KR; Stowell MHB; Old WM
    Commun Biol; 2020 Feb; 3(1):75. PubMed ID: 32060372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal proteome profiling for interrogating protein interactions.
    Mateus A; Kurzawa N; Becher I; Sridharan S; Helm D; Stein F; Typas A; Savitski MM
    Mol Syst Biol; 2020 Mar; 16(3):e9232. PubMed ID: 32133759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification.
    Chen X; Wang Y; Ma N; Tian J; Shao Y; Zhu B; Wong YK; Liang Z; Zou C; Wang J
    Signal Transduct Target Ther; 2020 May; 5(1):72. PubMed ID: 32435053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.